- Home
- CHNR vs CVKD Comparison
CHNR vs CVKD Comparison
Compare CHNR & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- CVKD
- Stock Information
- Founded
- CHNR N/A
- CVKD 2022
- Country
- CHNR China
- CVKD United States
- Employees
- CHNR N/A
- CVKD N/A
- Industry
- CHNR Precious Metals
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CHNR Basic Materials
- CVKD Health Care
- Exchange
- CHNR Nasdaq
- CVKD Nasdaq
- Market Cap
- CHNR 4.6M
- CVKD 29.5M
- IPO Year
- CHNR 1995
- CVKD 2023
- Fundamental
- Price
- CHNR $3.82
- CVKD $11.47
- Analyst Decision
- CHNR
- CVKD Strong Buy
- Analyst Count
- CHNR 0
- CVKD 1
- Target Price
- CHNR N/A
- CVKD $32.00
- AVG Volume (30 Days)
- CHNR 150.7K
- CVKD 33.0K
- Earning Date
- CHNR 05-15-2025
- CVKD 08-06-2025
- Dividend Yield
- CHNR N/A
- CVKD N/A
- EPS Growth
- CHNR N/A
- CVKD N/A
- EPS
- CHNR N/A
- CVKD N/A
- Revenue
- CHNR N/A
- CVKD N/A
- Revenue This Year
- CHNR N/A
- CVKD N/A
- Revenue Next Year
- CHNR N/A
- CVKD N/A
- P/E Ratio
- CHNR N/A
- CVKD N/A
- Revenue Growth
- CHNR N/A
- CVKD N/A
- 52 Week Low
- CHNR $3.57
- CVKD $5.70
- 52 Week High
- CHNR $9.04
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- CHNR 44.82
- CVKD 40.38
- Support Level
- CHNR $3.66
- CVKD $10.02
- Resistance Level
- CHNR $4.30
- CVKD $13.71
- Average True Range (ATR)
- CHNR 0.67
- CVKD 1.08
- MACD
- CHNR -0.04
- CVKD -0.13
- Stochastic Oscillator
- CHNR 9.64
- CVKD 29.72
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.